Absence of terminal deoxynucleotidyl transferase expression in T‐ALL / LBL accumulates chromosomal abnormalities to induce drug resistance
International Journal of Cancer · 2023
DOI: 10.1002/ijc.34465 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2023. Verfasst von Hui Xiao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology & Oncology, Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, School of Medicine, Shanghai Jia…. Hauptthemen laut MEDLINE: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
T‐acute lymphoblastic leukemia/lymphoma (T‐ALL/LBL) is a malignant neoplasm of immature lymphoblasts. Terminal deoxynucleotidyl transferase (TDT) is a template‐independent DNA polymerase that plays an essential role in generating diversity for immunoglobulin genes. T‐ALL/LBL patients with TDT − have a worse prognosis. However, how TDT − promotes the disease progression of T‐ALL/LBL remains unknown. Here we analyzed the prognosis of T‐ALL/LBL patients in Shanghai Children's Medical Center (SCMC) and confirmed that TDT − patients had a higher rate of recurrence and remission failure and worse outcomes. Cellular experiments demonstrated that TDT was involved in DNA damage repair. TDT knockout delayed DNA repair, arrested the cell cycle and decreased apoptosis to induce the accumulation of chromosomal abnormalities and tolerance to abnormal karyotypes. Our study demonstrated that the poor outcomes in TDT − T‐ALL/LBL might be due to the drug resistance (VP16 and MTX) induced by chromosomal abnormalities. Our findings revealed novel functions and mechanisms of TDT in T‐ALL/LBL and supported that hematopoietic stem cell transplantation (HSCT) might be a better choice for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology & Oncology, Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, National Health Committee Key Laboratory of Pediatr…
ORCID-Profile: Yanxin Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xiao, H., Wang, S., Tang, Y., Li, S., Jiang, Y., Yang, Y., Zhang, Y., Han, Y., Wu, X., Zheng, L., Li, Y., & Gao, Y. (2023). Absence of terminal deoxynucleotidyl transferase expression in T‐ALL / LBL accumulates chromosomal abnormalities to induce drug resistance. International Journal of Cancer. https://doi.org/10.1002/ijc.34465
Vancouver
Xiao H, Wang S, Tang Y, Li S, Jiang Y, Yang Y, et al. Absence of terminal deoxynucleotidyl transferase expression in T‐ALL / LBL accumulates chromosomal abnormalities to induce drug resistance. International Journal of Cancer. 2023. doi:10.1002/ijc.34465
BibTeX
@article{Xiao2023,
author = {Xiao, Hui and Wang, Siqi and Tang, Yuejia and Li, Shanshan and Jiang, Yufeng and Yang, Yi and Zhang, Yinwen and Han, Yali and Wu, Xiaoyu and Zheng, Liang and Li, Yanxin and Gao, Yijin},
title = {Absence of terminal deoxynucleotidyl transferase expression in T‐ALL / LBL accumulates chromosomal abnormalities to induce drug resistance},
journal = {International Journal of Cancer},
year = {2023},
doi = {10.1002/ijc.34465}
}
EUVIMED